PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC).

导出 LinkOut

翻译打印收藏纠错

第一作者： Wenbin,Jin

第一单位： Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.;Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518000, China.

作者： Wenbin,Jin ^[1] ; Li,Yan ^[2] ; Linlin,Li ^[3] ; Yang,Luo ^[2] ; Jinping,Qiao ^[2] ; Qiyu,Peng ^[4] ; Zhaohui,Zhu ^[3] ; Lin,Zhu ^[2] ; Hank F,Kung ^[5]

作者单位： Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.;Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518000, China. ^[1] Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China. ^[2] Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China. ^[3] Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518000, China. ^[4] Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. ^[5]